| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/30/2010 | US20100247662 Biologic Modulations with Nanoparticles |
| 09/30/2010 | US20100247641 Mechanical protective layer for solid dosage forms |
| 09/30/2010 | US20100247637 Compositions and pharmaceutical forms for the oral administration of thyroid hormones able to combat the action of sequestrants in the gastrointestinal tract |
| 09/30/2010 | US20100247635 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 09/30/2010 | US20100247633 Polypeptide Films and Methods |
| 09/30/2010 | US20100247614 Hemostatic wound dressing |
| 09/30/2010 | US20100247610 Gastric retained gabapentin dosage form |
| 09/30/2010 | US20100247600 Therapeutic drug eluting implant cover and method of making the same |
| 09/30/2010 | US20100247598 Thick foams for biomedical application and methods of making |
| 09/30/2010 | US20100247473 Polymeric thickener composition |
| 09/30/2010 | US20100247460 Silicone Organic Elastomer Gels From Organopolysiloxane Resins |
| 09/30/2010 | US20100247447 Drug delivery system for hydrophobic drugs |
| 09/30/2010 | US20100247439 Dendritic nano-antioxidants |
| 09/30/2010 | DE102009012788A1 Verpressbares Tablettenmaterial mit ölhaltigem Wirkstoff, Tablette sowie Verfahren und Vorrichtung zu deren Herstellung Compressible tablet material with oily active ingredient, tablet and method and apparatus for the preparation thereof |
| 09/30/2010 | CA2756941A1 Compositions and methods for treatment of hemorrhage |
| 09/30/2010 | CA2756924A1 Methods of identifying potential components for targeted drug delivery compositions |
| 09/30/2010 | CA2756883A1 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 09/30/2010 | CA2756853A1 Drug fusions and conjugates |
| 09/30/2010 | CA2756636A1 Compositions and methods for preferential distribution of active agents to injury sites |
| 09/30/2010 | CA2756580A1 A stable iron oligosaccharide compound |
| 09/30/2010 | CA2756428A1 Matrix-type sustained release preparation containing basic additive |
| 09/30/2010 | CA2756181A1 Carrier |
| 09/30/2010 | CA2756065A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions |
| 09/30/2010 | CA2756000A1 Method for preparing suspensions of low-solubility materials |
| 09/30/2010 | CA2755692A1 Solid preparation |
| 09/30/2010 | CA2755687A1 Anti-adhesive composition, solid preparation, and process for producing the same |
| 09/30/2010 | CA2754691A1 Dry powder formulations and methods for treating pulmonary diseases |
| 09/30/2010 | CA2754684A1 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining |
| 09/30/2010 | CA2754680A1 Pharmaceutical formulations and methods for treating respiratory tract infections |
| 09/30/2010 | CA2754677A1 Methods for treating and preventing pneumonia and ventilator-associated tracheobronchitis |
| 09/30/2010 | CA2754670A1 Anti-influenza formulations and methods |
| 09/30/2010 | CA2753388A1 Compounds compositions and methods of treating cancer and fibrotic diseases |
| 09/29/2010 | EP2233504A1 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 09/29/2010 | EP2233437A1 Nanofunctional silica particles and manufacturing method thereof |
| 09/29/2010 | EP2233156A2 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 09/29/2010 | EP2233155A2 Therapeutic polyanhydride compounds for drug delivery |
| 09/29/2010 | EP2233154A1 Skin external preparation |
| 09/29/2010 | EP2233144A1 Chitosan-containing compositions and process for production thereof |
| 09/29/2010 | EP2233142A1 Transdermally absorptive preparation |
| 09/29/2010 | EP2233139A1 Minoxidil aqueous composition containing bile acid |
| 09/29/2010 | EP2233138A1 Tape preparation comprising etodolac in ionic liquid form |
| 09/29/2010 | EP2233133A1 Stable Rosuvastatin Compositions |
| 09/29/2010 | EP2231765A2 Polysaccharide nanoparticles |
| 09/29/2010 | EP2231711A1 Hydroxyalkyl starch derivatives and process for their preparation |
| 09/29/2010 | EP2231710A1 Method for producing a hydroxyalkyl starch derivative with two linkers |
| 09/29/2010 | EP2231196A2 Increase of immune response and targeting by antigens and/or drug linkage |
| 09/29/2010 | EP2231194A2 Folate-irna conjugates |
| 09/29/2010 | EP2231193A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231192A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
| 09/29/2010 | EP2231191A2 Formulation of insulinotropic peptide conjugates |
| 09/29/2010 | EP2231190A1 Particulate drug carriers as desensitizing agents |
| 09/29/2010 | EP2231189A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 09/29/2010 | EP2231185A1 Methods and compositions for treating liquid tumors |
| 09/29/2010 | EP2231134A1 Biocompatible and biodegradable biopolymer matrix |
| 09/29/2010 | EP2231131A2 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 09/29/2010 | EP2231122A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 09/29/2010 | EP2231119A1 Pharmaceutical foams |
| 09/29/2010 | EP2231115A1 Transcutaneous pharmaceutical compositions containing a steroid hormone |
| 09/29/2010 | EP2230932A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 09/29/2010 | EP2230911A1 Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
| 09/29/2010 | EP1881850B1 Glp-1 pegylated compounds |
| 09/29/2010 | EP1652535B1 Semi-solid mucoadhesive formulations |
| 09/29/2010 | EP1649864B1 Periodontal disease therapeutic and/or preventive composition |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1425077B1 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 09/29/2010 | EP1413294B1 Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | CN1899287B Slow release medicinal composition for treating anxiety and its preparing method |
| 09/29/2010 | CN1893919B Endoparasiticidal agents for topical application |
| 09/29/2010 | CN1867580B Compound modified with glycerol derivative |
| 09/29/2010 | CN1695740B Composite body of fiber protein adhesive and antibiotics in use for treating infection in deep part, and application |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine |
| 09/29/2010 | CN101848739A Surgical hydrogel |
| 09/29/2010 | CN101848735A Novel neurturin conjugates for pharmaceutical use |
| 09/29/2010 | CN101848734A Labelled IIGF binding peptides for imaging |
| 09/29/2010 | CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation |
| 09/29/2010 | CN101848702A Micellar nanoparticles comprising botulinum toxin |
| 09/29/2010 | CN101848701A Water-immiscible materials as vehicles for drug delivery |
| 09/29/2010 | CN101848698A Oral dosage forms comprising licarbazepine acetate |
| 09/29/2010 | CN101845451A PEI (Polyetherimide)-chitosan triply compound gene vector with low molecular weight and preparation method and application thereof |
| 09/29/2010 | CN101845128A N-vinyl pyrrolidone and methyl methacrylate segmented copolymer and preparation method thereof |
| 09/29/2010 | CN101845120A Method for synthesizing temperature-sensitive and biodegradable in situ gel |
| 09/29/2010 | CN101845099A Long-acting analgesic peptide and application thereof |
| 09/29/2010 | CN101843896A Recombinant human interferon alpha 2b injection with high concentration and low filling quantity |
| 09/29/2010 | CN101843669A Chinese medicinal effective-part composition for treating coronary heart diseases |
| 09/29/2010 | CN101843663A Preparation method of extract package of volatile oil heavier than water |
| 09/29/2010 | CN101843651A Method for preparing folium cortex eucommiae extract microcapsules |
| 09/29/2010 | CN101843643A Chao'an tablet as well as prescription and preparation method thereof |
| 09/29/2010 | CN101843621A TS-1 granules and preparation method thereof |
| 09/29/2010 | CN101843616A Composition of fexofenadine hydrochloride and microcrystalline cellulose and preparation method thereof |
| 09/29/2010 | CN101843614A Application of metronidazole or its pharmacologically acceptable derivative |
| 09/29/2010 | CN101843613A Vitamin EC chewable tablets with high stability and preparation method thereof |
| 09/29/2010 | CN101843607A Composition containing ibutilide fumarate and preparation method and application thereof |
| 09/29/2010 | CN101843604A Isosorbide dinitrate patch and preparation method thereof |
| 09/29/2010 | CN101843603A Transdermal delivery of hormones without the need of penetration enhancers |
| 09/29/2010 | CN101843602A Patch and patch preparation |
| 09/29/2010 | CN101843601A Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 09/29/2010 | CN101843600A Quick-release capsules of proton pump inhibitor |